Ocugen Analyst Ratings
BenzingaApr 22 07:44 ET
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Ocugen (OCGN) and Moderna (MRNA)
TipRanksApr 9 08:10 ET
Ocugen Analyst Ratings
BenzingaApr 3 06:45 ET
Buy Rating Affirmed for Ocugen on Strong Clinical Progress and Financial Stability
TipRanksApr 3 06:25 ET
Ocugen Analyst Ratings
BenzingaFeb 22 06:45 ET
Buy Rating Affirmed for Ocugen on Strong Clinical Progress and Positive Financial Outlook
TipRanksFeb 22 06:20 ET
Ocugen Analyst Ratings
BenzingaJan 24 06:17 ET
Analyst Gives 'Buy' Rating to Ocugen Backed by Strong Financial Position and Promising Drug Pipeline
TipRanksNov 10, 2023 12:55 ET
H.C. Wainwright Sticks to Their Buy Rating for Ocugen (OCGN)
TipRanksSep 14, 2023 10:05 ET
Cantor Fitzgerald Maintains Overweight on Ocugen, Lowers Price Target to $2
BenzingaAug 31, 2023 10:19 ET
Ocugen Analyst Ratings
BenzingaAug 31, 2023 10:18 ET
Ocugen (OCGN) Gets a Buy From Noble Financial
TipRanksAug 23, 2023 08:05 ET
Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), LAVA Therapeutics (LVTX) and Ocugen (OCGN)
TipRanksAug 23, 2023 06:20 ET
HC Wainwright & Co. Reiterates Buy on Ocugen, Maintains $5 Price Target
BenzingaAug 23, 2023 06:15 ET
Ocugen Analyst Ratings
BenzingaAug 23, 2023 06:15 ET
Ocugen (OCGN) Gets a Buy From Noble Financial
TipRanksMay 8, 2023 08:11 ET
Chardan Research Raises Ocugen's Price Target to $4 From $3.50, Buy Rating Kept
MT NewswiresMay 8, 2023 07:11 ET
Chardan Capital Maintains Buy on Ocugen, Raises Price Target to $4
BenzingaMay 8, 2023 04:33 ET
Mizuho Securities Keeps Their Buy Rating on Ocugen (OCGN)
TipRanksMay 5, 2023 18:55 ET
Analyst Ratings for Ocugen
BenzingaApr 17, 2023 16:03 ET
No Data
No Data